Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease

Fig. 2

Overall survival follow-up of patients with CIP. Abbreviations: AE, adverse events; BR, best response; CIP, checkpoint inhibitors related pneumonitis; COPD, chronic obstructive pulmonary disease; G, grade of toxicity according to common terminology criteria for adverse events; PR, partial response; SD, stable disease

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us